CIK 0001691082 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
LB PHARMACEUTICALS INC
Sign in to watch- Ticker
- LBRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 917-450-6581
- Business address
- 575 MADISON AVENUE, NEW YORK, NY, 10022
- Former names
- LB PHARMACEUTICALS INC.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-09-10 | PANOFF MARC L Senior Vice President, Finance | Grant or award · Employee Stock Option (Right to Buy) | +90,525 | 90,525 | ||
| 2025-09-10 | Hemrajani Rekha Director | Grant or award · Stock Option (Right to Buy) | +22,449 | 22,449 | ||
| 2025-09-10 | Luse Rebecca Director | Grant or award · Stock Option (Right to Buy) | +22,449 | 22,449 | ||
| 2025-09-10 | Kane William P Jr Director | Grant or award · Stock Option (Right to Buy) | +22,449 | 22,449 | ||
| 2025-09-10 | RUFFOLO ROBERT R Director | Returned to the company · Stock Option (Right to Buy) | −1,792 | 0 | ||
| 2025-09-10 | RUFFOLO ROBERT R Director | Grant or award · Stock Option (Right to Buy) | +1,792 | 1,792 | ||
| 2025-09-10 | RUFFOLO ROBERT R Director | Returned to the company · Stock Option (Right to Buy) | −717 | 0 | ||
| 2025-09-10 | RUFFOLO ROBERT R Director | Grant or award · Stock Option (Right to Buy) | +717 | 717 | ||
| 2025-09-10 | RUFFOLO ROBERT R Director | Returned to the company · Stock Option (Right to Buy) | −10,757 | 0 | ||
| 2025-09-10 | RUFFOLO ROBERT R Director | Grant or award · Stock Option (Right to Buy) | +10,757 | 10,757 | ||
| 2025-09-10 | RUFFOLO ROBERT R Director | Grant or award · Stock Option (Right to Buy) | +22,449 | 22,449 | ||
| 2025-09-10 | PRENSKY ZACHARY Director | Returned to the company · Stock Option (Right to Buy) | −3,944 | 0 | ||
| 2025-09-10 | PRENSKY ZACHARY Director | Grant or award · Stock Option (Right to Buy) | +3,944 | 3,944 | ||
| 2025-09-10 | PRENSKY ZACHARY Director | Returned to the company · Stock Option (Right to Buy) | −896 | 0 | ||
| 2025-09-10 | PRENSKY ZACHARY Director | Grant or award · Stock Option (Right to Buy) | +896 | 896 | ||
| 2025-09-10 | PRENSKY ZACHARY Director | Returned to the company · Stock Option (Right to Buy) | −1,255 | 0 | ||
| 2025-09-10 | PRENSKY ZACHARY Director | Grant or award · Stock Option (Right to Buy) | +1,255 | 1,255 | ||
| 2025-09-10 | PRENSKY ZACHARY Director | Returned to the company · Stock Option (Right to Buy) | −17,929 | 0 | ||
| 2025-09-10 | PRENSKY ZACHARY Director | Grant or award · Stock Option (Right to Buy) | +17,929 | 17,929 | ||
| 2025-09-10 | PRENSKY ZACHARY Director | Returned to the company · Stock Option (Right to Buy) | −53,787 | 0 |
Page 3 of 5 · 84 trades